Utah Medical Products, Inc. (NASDAQ:UTMD) Shares Purchased by Cardinal Capital Management

Cardinal Capital Management increased its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 7.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 19,784 shares of the medical instruments supplier’s stock after acquiring an additional 1,336 shares during the quarter. Cardinal Capital Management owned approximately 0.58% of Utah Medical Products worth $1,222,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in UTMD. Golden State Wealth Management LLC acquired a new stake in shares of Utah Medical Products during the fourth quarter valued at about $31,000. R Squared Ltd purchased a new stake in Utah Medical Products in the fourth quarter valued at approximately $49,000. Copeland Capital Management LLC acquired a new position in Utah Medical Products during the third quarter worth $53,000. BNP Paribas Financial Markets grew its position in Utah Medical Products by 102.7% in the 3rd quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier’s stock valued at $75,000 after acquiring an additional 566 shares in the last quarter. Finally, SG Americas Securities LLC purchased a new stake in Utah Medical Products during the fourth quarter worth about $157,000. Institutional investors and hedge funds own 69.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded shares of Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 7th.

Utah Medical Products Trading Down 1.2 %

Utah Medical Products stock opened at $61.05 on Tuesday. The firm has a market capitalization of $206.96 million, a P/E ratio of 15.46 and a beta of 0.08. The stock’s fifty day simple moving average is $61.70 and its 200-day simple moving average is $64.62. Utah Medical Products, Inc. has a twelve month low of $58.87 and a twelve month high of $77.33.

Utah Medical Products (NASDAQ:UTMD) last posted its quarterly earnings results on Tuesday, January 28th. The medical instruments supplier reported $0.86 earnings per share (EPS) for the quarter. Utah Medical Products had a return on equity of 11.07% and a net margin of 33.92%.

Utah Medical Products Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 3rd. Shareholders of record on Friday, March 14th will be paid a $0.305 dividend. This represents a $1.22 dividend on an annualized basis and a yield of 2.00%. The ex-dividend date is Friday, March 14th. Utah Medical Products’s dividend payout ratio is presently 30.89%.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.